戻る Agenda
Session 5: The IND in Detail - Additional Topics
Session Chair(s)
Elliott Berger, PHD, MS
President
ETB Regulatory Consulting, United States
- Additional Requirements for Biologics and Biotechnology-Derived Products
- Submission of an Original IND